Stanley C. Erck

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2023

3 years of board service in total across 1 board, counting each seat separately. Longest: MaxCyte Inc., 3 years.

MaxCyte Inc. Director
3 years ยท Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jun 17, 2026 MaxCyte Inc. Grant or award +30,421 โ€” โ€”
Aug 13, 2025 MaxCyte Inc. Open-market purchase +100,000 $1.37 $137,000
Jun 18, 2025 MaxCyte Inc. Grant or award +29,210 โ€” โ€”
Nov 1, 2024 MaxCyte Inc. Option exercise +47,689 $0.04 $1,908
Nov 1, 2024 MaxCyte Inc. Open-market sale โˆ’47,689 $3.72 $177,403
Oct 2, 2024 MaxCyte Inc. Option exercise +21,607 $0.04 $864
Oct 2, 2024 MaxCyte Inc. Open-market sale โˆ’21,607 $3.71 $80,162
Oct 1, 2024 MaxCyte Inc. Option exercise +26,082 $0.04 $1,043
Oct 1, 2024 MaxCyte Inc. Open-market sale โˆ’26,082 $3.78 $98,590
Sep 4, 2024 MaxCyte Inc. Option exercise +29,767 $0.04 $1,191
Sep 4, 2024 MaxCyte Inc. Open-market sale โˆ’29,767 $3.97 $118,175
Sep 3, 2024 MaxCyte Inc. Option exercise +17,922 $0.04 $717
Sep 3, 2024 MaxCyte Inc. Open-market sale โˆ’17,922 $4.10 $73,480
Jun 11, 2024 MaxCyte Inc. Grant or award +21,367 โ€” โ€”

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.